


































Source: Keim, G; Watson, RS; Thomas NJ; Yehya, N. New Morbidity and Discharge Disposition of  Pediatric 
Acute Respiratory Distress Syndrome Survivors. Crit Care Med 2018; 46:1731–1738.
Pediatric acute respiratory distress syndrome (PARDS) causes significant disease burden in Pediatric Intensive Care Units (PICUs) with a reported prevalence of  close to 3%1 and short-term mortality rates up to 20%2. However, following 
PICUs tendency to exchange higher mortality rates for higher morbidity rates, 
PARDS research needs to focus on data about survivors and mortality cannot be the 
only outcome. 
The article uses a scale created as an outcome measure for use in pediatric 
research called the Functional Status Scale (FSS). New morbidity is defined as a 3 point 
increase in the scale. The authors aimed to determine new morbidity rate using change 
in FSS, hospital discharge disposition and 1 and 3 year mortality for survivors of  
PARDS. Also, researchers tried to establish epidemiologic, physiologic and treatment 
factors associated with these outcomes.
 The cohort consisted of  consecutive PICU patients from the Children’s 
Hospital of  Philadelphia’s (CHOP), eligible between July 1, 2011 and December 31, 2014, 
who met the former criteria for Acute Lung Injury. There is a new definition for PARDS 
since 2015, but all patients would even though meet this diagnosis. The following data 
were collected in the study: demographics data, Pediatric Risk of  Mortality (PRISM) III, 
preillness FSS and at hospital discharge, ventilator settings and Pao2/Fio2 at PARDS 
onset and 24 hours, laboratory data, medications for the first 3 days of  PARDS and 
nonpulmonary organ failures at time of  PARDS diagnosis. The main outcome was 
status at hospital discharge, trichotomized to alive without new morbidity, alive with 
new morbidity, and dead.
 Among the 316 patients diagnosed with PARDS, the inhospital mortality 
rate was 13,3%. Survivors accounted for 274 patients – 77% survived without new 
morbidity and 23% survived with new morbidity. Those outcomes correlated well 
with severity of  illness, non-pulmonary organ failures and severity of  PARDS at 24 
hours. There was a stepwise increase in each of  these severity of  illness markers, with 
survivors without new morbidity demonstrating better values, non- survivors the 
worst, and survivors with new morbidity having intermediate values. They divide the 
outcomes as good (alive without new morbidity) versus poor (new morbidity or death), 
and poor outcome was associated with PRISM III, nonpulmonary organ failures, 
immunocompromising comorbidities, and oxygenation and ventilator pressures 24 
hours after PARDS onset.
 Within the survivors, 72,3% were discharged home, 24,5% needed 
rehabilitation and 3,3% where transferred to chronic care facilities. A FSS greater than 
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or equal to 3 was strongly associated with discharge to rehabilitation, with highest 
declines in feeding, motor and respiratory functional domains. Regarding respiratory 
outcomes, 20,4% (56 patients) of  hospital survivors had change in FSS. Of  these, 
19 patients underwent tracheostomy placement. Of  the 56 patients with a change 
in respiratory FSS, 17 (30.4%) had improvement in their respiratory FSS by 3-year 
follow-up, 10 (17.9%) had returned to a nonmorbid FSS of  1, but seven died within the 
first year after PARDS and one additional patient died by 3-year follow-up. One and 
three-year mortality were 5,5% and 8%, respectively. One- and 3-year mortality in 
survivors of  PARDS was most strongly predicted by immunocompromised status and 
higher baseline FSS, with weaker association with PRISM III score, suggesting baseline 
disease would influence more than PARDS itself  to the prognosis.
Commentary by: Ana Cecília Aziz, MD.
Pediatric Intensivist at Complexo Hospitalar de Niterói, 
Hospital Getúlio Vargas Filho and Hospital Copa D’Or.
The issue discussed in this article is extremely important, since PARDS 
continues to be an important syndrome in PICU, affecting 3%1 of  PICUs patients. 
With increasing technology, advances in the use of  extracorporeal membrane 
oxygenation (ECMO), protective ventilatory strategies and understanding of  PARDS 
pathophysiology, mortality has lowered and survival with new morbidities is becoming 
a more robust outcome to be measured. The FSS is a functional status outcome 
measure for large studies that is well defined, quantitative, rapid, reliable, objective 
and suitable for a wide spectrum of  ages. It includes 6 domains: mental status, sensory, 
communication, motor, feeding and respiratory, categorized from normal (1) to very 
severe dysfunction (5)3. 
It is the first study relating PARDS and functional outcomes. The authors 
showed that variables associated with inhospital mortality also related to new 
morbidity and new morbidity exists on an intermediate step along the continuum 
of  intact survival to death. FSS seems to be a useful outcome measure in PARDS. 
These results confirm previous findings from a large study from Pollack et al4, which 
showed that increasing PRISM III scores was also associated with development of  new 
morbidity and that new morbidity was a more common outcome than mortality5. 
A cornerstone of  improving critical care is early mobilization and 
rehabilitation6,7. CHOP had a well-developed rehabilitation center and the integration 
of  early physical therapy services and an active rehabilitative medicine team with 
an associated inpatient rehabilitation unit may have contributed to better outcomes 
without new morbidity and early return to basal FSS after hospital discharge. 
Follow-up FSS scores would be helpful in knowing the effect of  the rehabilitation 
interventions on the dysfunction associated with PARDS. 
Finally, detecting new morbidities allows for the study of  new interventions to 
reduce the consequences of  PICU hospitalization, not only related to the 
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